The substitution solution Prismasol B0 is potassium-free. The serum potassium concentration must be monitored before and during hemofiltration and/or hemodialysis.
The electrolyte solution must be mixed with the buffer solution before use to obtain the final solution suitable for haemofiltration/haemodiafiltration/continuous haemodialysis.
Use only with appropriate extracorporeal renal replacement equipment.
Because the solution contains no glucose, administration may lead to hypoglycemia. Blood glucose levels should be monitored regularly.
Prismasol B0 contains hydrogen carbonate (bicarbonate), and lactate (a hydrogen carbonate precursor) which can influence the patient's acid–base balance. If metabolic alkalosis develops or worsens during therapy with the solution, the administration rate may need to be decreased, or the administration stopped.
The use of contaminated haemofiltration solution may cause sepsis, shock and fatal conditions.